George A. Scangos - Feb 17, 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
Feb 17, 2023
Transactions value $
-$755,517
Form type
4
Date filed
2/21/2023, 06:29 PM
Previous filing
Mar 21, 2022
Next filing
Feb 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Other $0 -50K -5.7% $0.00 827K Dec 21, 2022 See footnote F1, F2
transaction VIR Common Stock Other $0 +50K +81.06% $0.00 112K Dec 21, 2022 See footnote F1, F3
transaction VIR Common Stock Other $0 -50K -5.7% $0.00 827K Dec 21, 2022 See footnote F1, F4
transaction VIR Common Stock Other $0 +50K +81.06% $0.00 112K Dec 21, 2022 See footnote F1, F5
transaction VIR Common Stock Other $0 -64.9K -1.8% $0.00 3.53M Jan 18, 2023 See footnote F1, F6
transaction VIR Common Stock Other $0 +64.9K +56.46% $0.00 180K Jan 18, 2023 See footnote F1, F7
transaction VIR Common Stock Sale -$250K -9.89K -4.42% $25.29 214K Feb 17, 2023 Direct F8
transaction VIR Common Stock Sale -$319K -11.4K -5.32% $28.02 203K Feb 21, 2023 Direct F9, F10
transaction VIR Common Stock Sale -$186K -6.47K -3.19% $28.80 196K Feb 21, 2023 Direct F9, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer without consideration for tax planning purposes.
F2 The shares are held in the name of the Jennifer Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees.
F3 The shares are held in the name of the Jennifer Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees.
F4 The shares are held in the name of the Katherine Scangos 2018 Non-Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees.
F5 The shares are held in the name of the Katherine Scangos 2018 Exempt Trust, dated August 30, 2018, of which the reporting person and his spouse are Trustees.
F6 The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
F7 The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.
F8 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
F9 Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 29, 2022.
F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.49 to $28.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $29.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.